Intracranial yolk sac tumor in a patient with down syndrome: Case report

Journal of Neurosurgery: Pediatrics

Volumn 7, Issue 6, 2011, Pages 604-608

  Maeda, Yoshihiko ^a   Yoshikawa, Koichi ^a   Kajiwara, Koji ^a   Ideguchi, Makoto ^a   Amano, Takayuki ^a   Saka, Makoto ^a   Nomura, Sadahiro ^a   Fujii, Masami ^a   Suzuki, Michiyasu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain tumor; Chemotherapy; Down syndrome; Germ cell tumor; Oncology; Yolk sac tumor

Indexed keywords

ALPHA FETOPROTEIN; ANTIBIOTIC AGENT; CISPLATIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE;

ADOLESCENT; ARTICLE; BASAL GANGLION; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; DOSE RESPONSE; DOWN SYNDROME; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; HEMIPARESIS; HUMAN; INTRACRANIAL YOLK SAC TUMOR; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION DOSE; SEROLOGY; THROMBOCYTE TRANSFUSION; TREATMENT RESPONSE; TUMOR RECURRENCE; TUMOR VOLUME; YOLK SAC TUMOR;

ADOLESCENT; ALPHA-FETOPROTEINS; ANTINEOPLASTIC AGENTS; BASAL GANGLIA; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; DOWN SYNDROME; ENDODERMAL SINUS TUMOR; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; RADIOTHERAPY, ADJUVANT; TUMOR MARKERS, BIOLOGICAL;

EID: 79958035227     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2011.3.PEDS10500     Document Type: Article

References (29)

1. Aupérin A, Le Péchoux C, Rolland E, Curran WJ, Furuse K, Fournel P, et al: Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 28:2181-2190, 2010
2. Baek HK, Zaslavsky A, Lynch RC, Britt C, Okada Y, Slarey RJ, et al: Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459:1126-1130, 2009
3. Chik K, Li C, Shing MM, Leung T, Yuen PM: Intracranial germ cell tumors in children with and without Down syndrome. J Pediatr Hematol Oncol 21:149-151, 1999 (Pubitemid 30303879)
4. Creutzig U, Ritter J, Vormoor J, Ludwig WD, Niemeyer C, Reinisch I, et al: Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group. Leukemia 10:1677-1686, 1996 (Pubitemid 26380009)
5. Fujita T, Yamada K, Saitoh H, Itoh S, Nakai O: Intracranial germinoma and Down's syndrome - case report. Neurol Med Chir (Tokyo) 32:163-165, 1992
6. Gamis AS: Acute myeloid leukemia and Down syndrome evolution of modern therapy - state of the art review. Pediatr Blood Cancer 44:13-20, 2005
7. Gamis AS, Woods WG, Alonzo TA, Buxton A, Lange B, Barnard DR, et al: Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891. J Clin Oncol 21:3415-3422, 2003 (Pubitemid 46594074)
8. Ge Y, Stout ML, Tatman DA, Jensen TL, Buck S, Thomas RL, et al: GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia. J Natl Cancer Inst 97:226-231, 2005 (Pubitemid 40277373)
9. Komiya K, Iwamoto H, Misugi K: [Cerebellar tumor in a child with Down's syndrome.] Abstracts of Papers Presented at the Fifteenth Annual Meeting of the Congenital Anomalies Research Association of Japan, Tokyo, Japan, November 7-9, 1975. p 202 (http://onlinelibrary.wiley.com/doi/10.1002/tera.1420120211/pdf) [Accessed March 17, 2011] (Abstract) (Jpn)
10. Lange BJ, Kobrinsky N, Barnard DR, Arthur DC, Buckley JD, Howells WB, et al: Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891. Blood 91:608-615, 1998 (Pubitemid 28053385)
11. Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Klingebiel T, Creutzig U: Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia 18:72-77, 2004 (Pubitemid 38159441)
12. Levitt GA, Stiller CA, Chessells JM: Prognosis of Down's syndrome with acute leukaemia. Arch Dis Child 65:212-216, 1990 (Pubitemid 20057814)
13. Lie SO, Jonmundsson G, Mellander L, Siimes MA, Yssing M, Gustafsson G: A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Oncology (NOPHO). Br J Haematol 94:82-88, 1996 (Pubitemid 26232544)
14. Matsumura N, Kurimoto M, Endo S, Fukuda O, Takaku A: Intracranial germinoma associated with Down's syndrome. Report of 2 cases. Pediatr Neurosurg 29:199-202, 1998 (Pubitemid 29029799)
15. Matsutani M, Sano K, Takakura K, Fujimaki T, Nakamura O: Combined treatment with chemotherapy and radiation therapy for intracranial germ cell tumors. Childs Nerv Syst 14:59-62, 1998 (Pubitemid 28269424)
16. Nakashima T, Nishimura Y, Sakai N, Yamada H, Hara A: Germinoma in cerebral hemisphere associated with Down syndrome. Childs Nerv Syst 13:563-566, 1997 (Pubitemid 27517724)
17. Nakato H, Kuwabara S, Maesako N, Inomata H, Ishimoto F, Hashida K, et al: [A case of Down's syndrome complicated by teratoma of the third ventricle of the brain (author's transl).] No To Shinkei 34:145-150, 1982 (Jpn)
18. Oshita N, Yamashita K, Gotou H, Nagata I, Ueda H, Mitani T: [A case of endodermal sinus tumor in the basal ganglia associated with Down's syndrome.] No Shinkei Geka 21:345-349, 1993 (Jpn)
19. Peeters M, Poon A: Down syndrome and leukemia: unusual clinical aspects and unexpected methotrexate sensitivity. Eur J Pediatr 146:416-422, 1987 (Pubitemid 17130864)
20. Pignon JP, Le Maître A, Maillard E, Bourhis J: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4-14, 2009
21. Rickert CH, Göcke H, Paulus W: Fetal ependymoma associated with Down's syndrome. Acta Neuropathol 103:78-81, 2002 (Pubitemid 36075316)
22. Satgé D, Sasco AJ, Chompret A, Orbach D, Méchinaud F, Lacour B, et al: A 22-year French experience with solid tumors in children with Down syndrome. Pediatr Hematol Oncol 20:517-529, 2003 (Pubitemid 37248194)
23. Tan HW, Ty A, Goh SG, Wong MC, Hong A, Chuah KL: Pineal yolk sac tumour with a solid pattern: a case report in a Chinese adult man with Down's syndrome. J Clin Pathol 57:882-884, 2004 (Pubitemid 39061441)
24. Tanabe M, Mizushima M, Anno Y, Kondou S, Dejima S, Hirao DJ, et al: Intracranial germinoma with Down's syndrome: a case report and review of the literature. Surg Neurol 47:28-31, 1997 (Pubitemid 27009153)
25. Taub JW, Ge Y: Down syndrome, drug metabolism and chromosome 21. Pediatr Blood Cancer 44:33-39, 2005 (Pubitemid 39602563)
26. Ushio Y, Kochi M, Kuratsu J, Itoyama Y, Marubayashi T: Preliminary observations for a new treatment in children with primary intracranial yolk sac tumor or embryonal carcinoma. Report of five cases. J Neurosurg 90:133-137, 1999 (Pubitemid 29024750)
27. Wada H, Kubo M, Wada T, Ueno Y, Horita S, Ohki T, et al: [A case report of a 6-year-old boy with intracranial yolk sac tumor treated by VAB-6 regimen.] No Shinkei Geka 23:65-68, 1995 (Jpn)
28. Yamasaki S, Hamasaki Y: [A case of brain tumor in Down syndrome infant.] Arch Jpn Chir 54:305-313, 1985 (Jpn)
29. Zipursky A, Poon A, Doyle J: Leukemia in Down syndrome: a review. Pediatr Hematol Oncol 9:139-149, 1992